Showing all 6 results

• 
  Experimental

  Bronchogen

  £46.00
  20 mgBatch file pending

  Airway-tissue focus rather than VIP’s defined VPAC-receptor bronchodilatory biology.

  UnavailableAsk about availability
• 
  Preclinical

  KPV

  £27.47 – £29.99Price range: £27.47 through £29.99
  10 mgBatch file pending

  A minimal anti-inflammatory alpha-MSH fragment rather than an antimicrobial peptide such as LL-37.

  Available · 20 in stockAdd to basket This product has multiple variants. The options may be chosen on the product page
• 
  Early human evidence

  LL-37

  £59.00
  5 mgBatch file pending

  Direct antimicrobial membrane activity separates it from immune regulators such as KPV or thymosin alpha-1.

  UnavailableAsk about availability
• 
  Established

  Thymosin Alpha-1

  £69.00
  10 mgBatch file pending

  An immune-response modulator with human clinical literature, distinct from LL-37’s direct antimicrobial activity.

  UnavailableAsk about availability
• 
  Experimental

  Vilon

  £46.00
  20 mgBatch file pending

  A minimal dipeptide bioregulator, much smaller and less mechanistically defined than thymosin alpha-1.

  UnavailableAsk about availability
• 
  Clinical research

  VIP

  £29.99 – £38.99Price range: £29.99 through £38.99
  5 mgBatch file pending

  A receptor-defined pleiotropic neuropeptide with direct vasodilatory and bronchodilatory effects.

  UnavailableAsk about availability This product has multiple variants. The options may be chosen on the product page